Insights into the theranostic value of precision medicine on advanced radiotherapy to breast cancer.

ABSTRACT: Breast cancer is the most common cancer in women worldwide. "Breast cancer" encompasses a broad spectrum of diseases (i.e., subtypes) with significant epidemiological, clinical, and biological heterogeneity. Each of these subtypes has a different natural history and prognostic profile. Although tumour staging (TNM classification) still provides valuable information in the overall management of breast cancer, the current reality is that clinicians must consider other biological and molecular factors that directly influence treatment decision-making, including extent of surgery, indication for chemotherapy, hormonal therapy, and even radiotherapy (and treatment volumes). The management of breast cancer has changed radically in the last 15 years due to significant advances in our understandin

SUBMITTER: Jiang M 

PROVIDER: S-EPMC7797538 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature